Finance Watch: Amylyx, CinCor And Vigil Ready The First Biopharma IPOs Of 2022
First-Time US Offerings Could See A Strong Start
Public Company Edition: Mergers with special purpose acquisition corporations also continue to take companies public, with three new SPAC offerings in late 2021. Also, Xeris raised $30m in a private placement of stock to support its recently approved drug and Sirnaomics went public in Hong Kong.
